IMG Pharma to Acquire Matsumoto Pharmaceutical
IMG Pharma signs a definitive agreement to acquire Matsumoto Pharmaceutical, combining biopharmaceutical innovation with manufacturing and OTC capabilities, forming a multi-layered product capability structure.
Pharmaceutical Mergers And Acquisitions | 28/04/2026 | By News Bureau
Neurocrine to Acquire Soleno Therapeutics
Neurocrine to acquire Soleno Therapeutics, adding US FDA-approved VYKAT XR for Prader-Willi Syndrome and strengthening its rare disease and endocrinology portfolio.
Pharmaceutical Mergers And Acquisitions | 07/04/2026 | By News Bureau
Gilead Extends Tender Offer to Acquire Arcellx
Gilead extends tender offer to acquire Arcellx until April 24, 2026, providing additional time for shareholders to participate in the proposed acquisition.
Pharmaceutical Mergers And Acquisitions | 02/04/2026 | By News Bureau | 110
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy